Gilmore Neil O'Neill Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Gilmore Neil O'Neill.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Gilmore Neil O'Neill. Gilmore Neil O'Neill is EVP, R&D & CMO in Sarepta Therapeutics, Inc. ($SRPT) and SVP & Chief Medical Officer in Sarepta Therapeutics, Inc. ($SRPT) and Director in Unity Biotechnology, Inc. ($UBX).
Latest Insider Trading Transactions of Gilmore Neil O'Neill
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 28 2021 | UBX | Unity Biotechnolog ... | O'Neill Gilmore Neil | Director | Option Exercise | A | 4.18 | 13,425 | 56,117 | 13,425 | |
| Mar 05 2021 | SRPT | Sarepta Therapeuti ... | O'Neill Gilmore Neil | EVP, R&D & CMO | Option Exercise | A | 87.11 | 60,000 | 5,226,600 | 60,000 | |
| Mar 05 2021 | SRPT | Sarepta Therapeuti ... | O'Neill Gilmore Neil | EVP, R&D & CMO | Grant | A | 0.00 | 15,000 | 0 | 29,070 | 14.1 K to 29.1 K (+106.61 %) |
| Dec 14 2020 | UBX | Unity Biotechnolog ... | O'Neill Gilmore Neil | Director | Option Exercise | A | 6.12 | 50,000 | 306,000 | 50,000 | |
| Feb 28 2020 | SRPT | Sarepta Therapeuti ... | O'Neill Gilmore Neil | EVP, R&D & CMO | Option Exercise | A | 114.47 | 37,500 | 4,292,625 | 37,500 | |
| Feb 28 2020 | SRPT | Sarepta Therapeuti ... | O'Neill Gilmore Neil | EVP, R&D & CMO | Grant | A | 0.00 | 6,700 | 0 | 14,070 | 7.4 K to 14.1 K (+90.91 %) |
| May 24 2019 | SRPT | Sarepta Therapeuti ... | O'Neill Gilmore Neil | EVP, R&D & CMO | Option Exercise | M | 0.00 | 12,000 | 0 | 0 | |
| May 24 2019 | SRPT | Sarepta Therapeuti ... | O'Neill Gilmore Neil | EVP, R&D & CMO | Payment of Exercise | F | 119.31 | 4,630 | 552,405 | 7,370 | 12 K to 7.4 K (-38.58 %) |
| May 24 2019 | SRPT | Sarepta Therapeuti ... | O'Neill Gilmore Neil | EVP, R&D & CMO | Buy | M | 0.00 | 12,000 | 0 | 12,000 | 0 to 12 K |
| Mar 04 2019 | SRPT | Sarepta Therapeuti ... | O'Neill Gilmore Neil | EVP, R&D & CMO | Option Exercise | A | 145.48 | 55,000 | 8,001,400 | 55,000 | |
| Jun 11 2018 | SRPT | Sarepta Therapeuti ... | O'Neill Gilmore Neil | SVP & Chief Medical ... | Option Exercise | A | 0.00 | 12,000 | 0 | 12,000 | |
| Jun 11 2018 | SRPT | Sarepta Therapeuti ... | O'Neill Gilmore Neil | SVP & Chief Medical ... | Option Exercise | A | 96.23 | 100,000 | 9,623,000 | 100,000 |
Page: 1